What Are the Challenges in Implementing 3D Bioprinting in Toxicology?
Despite its potential, 3D bioprinting faces several challenges:
1. Technical Limitations: The technology is still evolving, and there are technical limitations related to the resolution, speed, and scalability of bioprinting. 2. Standardization: There is a lack of standardized protocols for bioprinting and toxicity testing, making it difficult to compare results across studies. 3. Cost: The initial investment in bioprinting equipment and bioinks can be high, although costs are expected to decrease as the technology matures. 4. Regulatory Hurdles: Regulatory agencies need to establish guidelines and frameworks for the use of bioprinted tissues in toxicological assessments.
